ASCO 2024: Artificial Intelligence and Deep Learning in Prostate Cancer Pathology
ASCO 2024, Prostate Cancer, Prostate Cancer Pathology, Artificial Intelligence and Deep Learning in Prostate Cancer Pathology, TMPRSS2:ERG fusion status.
Source: urotoday.com